Development and utility of pirfenidone in the treatment of idiopathic pulmonary fibrosis: review of preclinical science and recent clinical trials

  • Robert Robert M Jackson, Orlando Gomez-Marin
  • Transplant Research and Risk Management, April 2011, Taylor & Francis
  • DOI: 10.2147/trrm.s16205

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.2147/trrm.s16205

The following have contributed to this page: Robert Jackson